Summary
Recurrence and survival rates were studied in 222 patients with primary breast cancer with particular reference to relations with the estrogen and progesterone receptor content of the primary tumor, involvement of axillary lymph nodes and menopausal status. The median observation time for these 222 women was 46 months, the longest being 88 months and the shortest for recurrence-free survivors, being 42 months.
Within the first 4 years after primary surgery, recurrences occurred more rarely and later in patients with receptor-positive cancers. After 70 and 50 months, respectively, there was no longer any difference between estrogen receptor- and progesterone receptor-positive and receptor-negative cases.
The overall survival curve plotted in accordance with Kaplan and Meier [5] was more favourable for patients with estrogen receptor-positive carcinoma than for those with estrogen receptor-negative tumors, even after 6.5 years.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hähnel R, Woodings T, Vivian AB (1979) Prognostic value of estrogen receptors in primary breast cancer. Cancer 44: 671–675
Hilf R, Feldman ML, Gibson SL, Savlov ED (1980) The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45: 1993–2000
Jensen EV, Smith S, de Sombre ER (1976) Hormone dependency in breast cancer. J Steroid Biochem 7: 911–917
Jungblut PW, Hätzel I, de Sombre ER, Jensen EV (1967) Über Hormon-“Rezeptoren”. Die östrogenbildenden Prinzipien der Erfolgsorgane. 18. Colloquium der Gesellschaft für Physiologische Chemie vom 5. bis 8. April 1967 in Mosbach/Baden. Springer, Berlin Heidelberg New York
Kaplan EL, Meier P (1958) Non-parametric estimations from incomplete observations. J Am Stat Assoc 53: 457–482
Kinne DW, Ashikari R, Butler A, Menendenz-Botet C, Rosen PP, Schwartz M (1981) Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47: 2364–2367
Knight WA, Livingston BR, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Maass H, Engel B, Trams G, Nowakowski H, Stolzenbach G Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 6 : 743–749
Maillot K von, Hermanek P, Gentsch HH (1979) Steroid receptors in tumors of tissues generally considered to be hormoneindependent. J Cancer Res Clin Oncol 93: 77–84
Maillot K von, Gentsch HH, Gunselmann W (1980) Steroid receptors and response to endocrine treatment and chemotherapy of advanced breast cancer. J Cancer Res Clin Oncol 98: 301–313
Maillot K von, Egger H, Gunselmann W (1981) Fünf Jahre adjuvante Chemotherapie beim Mamma-Carcinom. Geburtshilfe Frauenheilkd 41: 461–464
McGuire WL, Carbone PP, Sears ME, Escher GC (1974) Estrogen receptors in human breast cancer. An overview. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen receptors in human breast cancer. Raven Press, New York, pp 1–7
Rainer H, Bettelheim P, Bieglmayer C, Chaput B, Jakesz R, Kees A, Kolb R, Mörz R, Moser K, Reiner G, Schemper M, Spona J (1980) Prognostische Bedeutung von Östrogenrezeptoren beim Mamma-Carcinom. Wien Klin Wochenschr 92: 796–800
Vogt-Hoerner G, Gerard-Marchand R (1958) Technique anatomopathologuque de recherche et d'examen des ganglions lymphatiques. Bull Cancer (Paris) 45: 446
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 118), “Grundlagen der Früherkennung und der Verlaufsbeobachtung des Krebses”
Rights and permissions
About this article
Cite this article
von Maillot, K., Horke, W. & Prestele, H. Prognostic significance of the steroid receptor content in primary breast cancer. Arch. Gynecol. 231, 185–190 (1982). https://doi.org/10.1007/BF02110117
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02110117